Tue.Jun 25, 2024

article thumbnail

The US Healthcare System vs…….South Park ?!?!

Noreta Family Medicine

The US Healthcare System vs…….South Park ?!?! I have to admit that I’ve never watched an episode of South Park. However, this clip was sent to me by another Direct Primary Care (DPC) doctor, and I thought that it was well done and that it deserved to be shared! Although the medical focus of this video is obesity, I was intrigued by the other highlighted theme – the endless spool of red tape in healthcare.

article thumbnail

The Interchangeables Are A-Changin’: New FDA Guidance Proposes Eliminating Switching Studies Requirements

FDA Law Blog

By Sara W. Koblitz — In a short but sweet Guidance issued last week, FDA proposed a dramatic change to the way it evaluates interchangeable biosimilars. For the last 14 years, an applicant could get approval of a biosimilar as a standard biosimilar or an interchangeable biosimilar, but the interchangeable biosimilar presented a higher hurdle to approval: Applicants needed to show that a patient could be switched from the Reference Product to the biosimilar and back without issue.